Increasing genetic diversity of HIV in the US

October 30, 2007

Who: HIV experts from the U.S Centers for Disease Control, University of Cologne and Selera Diagnostics

What: HIV Symposium at Association for Molecular Pathology (AMP) Annual Conference

When: Wednesday, Nov. 7, 9:00 to 10:00 am

Where: Hyatt Regency Century Plaza Hotel, Los Angeles

Why: Since the first diagnostic tests for the HIV virus came on the market in 1985, public health authorities have been concerned about HIV's ability to mutate and create new strains or subtypes that may elude detection.

As the world continues to shrink, studies suggest that the influx of immigrants to the US from countries where variant strains of HIV are more common is increasing the number of newly diagnosed patients infected with variant HIV. Optimal treatment of HIV depends on accurate measurement of viral levels. However, if variant subtypes are present and undetected, drug therapy could be ineffective.

During the AMP meeting, a special symposium will focus on the changing epidemiology of HIV and how it influences the accuracy of HIV diagnostic tests. Speakers will review several studies from CDC and other research institutions showing the alarming, rising prevalence of variant HIV subtypes in the US.

Speakers: Ulana Bodner, Commander, US Public Health Service, CDC

Rolf Kaiser, PhD, assistant professor, Institute for Virology, Univ. of Cologne

John Sninsky, vice president, discovery research, Celera Diagnostics
-end-
For further information: Journalists interested in reporting on the HIV symposium at the AMP meeting should contact Chuck Weber at 847-705-1802 or cpweber@weberpr.com. For those preferring to receive news releases via email direct from the meeting, please send an email requesting to be included on the distribution list.

Weber & Associates Public Relations

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.